Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00872495 · ClinicalTrials.gov registry record

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

A clinical trial of Cancer and Urothelial Cancer, sponsored by Lahey Clinic.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT00872495 is a study of Cancer and Urothelial Cancer that is actively recruiting participants, run by Lahey Clinic. The registered enrollment target is 500 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00872495, a study of Cancer and Urothelial Cancer, is actively recruiting participants, sponsored by Lahey Clinic.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence

Study Locations (1)

Massachusetts

  • Lahey Clinic, Inc. - Burlington

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2002-09
Est. Completion 2028-11

Sponsor

Lahey Clinic

43 total trials

What the Registry Record Tells You About NCT00872495

The ClinicalTrials.gov registry entry for NCT00872495 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT00872495 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00872495 about?

NCT00872495 is a clinical study titled "Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer". The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence

What is the current status of trial NCT00872495?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2002-09. Estimated completion is 2028-11.

What conditions does trial NCT00872495 study?

This clinical trial studies the following conditions: Cancer, Urothelial Cancer, Bladder Neoplasms, Urinary Bladder Cancer.

Who is sponsoring clinical trial NCT00872495?

This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00872495 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.